Search results
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg via Yahoo Finance· 20 hours ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
Amgen shares soar on obesity drug optimism By Proactive Investors
Investing.com· 19 hours agoAmgen Inc (NASDAQ:AMGN, ETR:AMG) shares gained almost 13% at about $314 in...the weight loss market....
Earnings call: Amgen reports robust Q1 2024 sales and pipeline progress By Investing.com
Investing.com· 17 hours agoThe biotechnology company has seen a 22% increase in sales, driven by key products such as Repatha,...
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com via Yahoo Finance· 1 day agoQ: What preparations...President) The manufacturing process for AMG 133, based on an antibody backbone, aligns with Amgen's expertise in biotherapeutic manufacturing. The ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 1 day agoShares of Amgen surged 13% in after hours trading. Investors are focused on Amgen's pipeline of...
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value...
Benzinga· 18 hours agoAmgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant...
Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral...
Benzinga· 1 day agoAmgen, Inc. AMGN shares rallied over 14% in Thursday’s after-hours trading after the biopharma...
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 2 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its ...
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1...
Benzinga· 5 days agoWith the earnings season now halfway through, the percentage of S&P 500 companies reporting positive...
Leukemia Therapeutics Market Expected to Grow at USD 13491.42 Million by 2030: SNS Insider
Digital Journal· 16 hours agoThe global leukemia therapeutics market has witnessed significant growth in recent years, driven by...